{"transactions":[{"id":717200,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-02T20:59:50.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option was granted on March 1, 2024 and vested 25% on the first anniversary of the date of grant, and vests 6.25% quarterly thereafter until fully vested."}],"balance_after":50500,"derivative":{"exercise_price":5.59,"expiration_date":"2034-03-01","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0000904454-26-000394","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000394/edgar.xml","form_type":"4"}},{"id":717199,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-02T20:59:50.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":46.4,"value":928000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.24 to $46.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote."}],"balance_after":148235,"source":{"system":"sec-edgar","filing":"0000904454-26-000394","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000394/edgar.xml","form_type":"4"}},{"id":717198,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-02T20:59:50.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":10000,"price":46.46,"value":464600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.97. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote."}],"balance_after":168235,"source":{"system":"sec-edgar","filing":"0000904454-26-000394","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000394/edgar.xml","form_type":"4"}},{"id":717197,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-02T20:59:50.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":10000,"price":5.59,"value":55900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":178235,"source":{"system":"sec-edgar","filing":"0000904454-26-000394","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000394/edgar.xml","form_type":"4"}},{"id":722590,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-30T21:06:47.000Z","date":"2026-06-26","kind":"sale","planned":false,"acquired":false,"shares":1434,"price":46.86,"value":67197.24,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.69 to $46.96. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":168235,"source":{"system":"sec-edgar","filing":"0000904454-26-000387","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000387/edgar.xml","form_type":"4"}},{"id":781970,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T20:54:32.000Z","date":"2026-05-08","kind":"exercise","planned":true,"acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The Stock Option was granted on March 1, 2024 and vested 25% on the first anniversary of the date of grant, and vests 6.25% quarterly thereafter until fully vested."}],"balance_after":60500,"derivative":{"exercise_price":5.59,"expiration_date":"2034-03-01","underlying":"Ordinary Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000904454-26-000260","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000260/edgar.xml","form_type":"4"}},{"id":781969,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-12T20:54:32.000Z","date":"2026-05-08","kind":"sale","planned":true,"acquired":false,"shares":20000,"price":25,"value":500000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":169669,"source":{"system":"sec-edgar","filing":"0000904454-26-000260","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000260/edgar.xml","form_type":"4"}},{"id":781968,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-12T20:54:32.000Z","date":"2026-05-08","kind":"sale","planned":true,"acquired":false,"shares":25000,"price":25.1,"value":627500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.00 to $25.29. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":189669,"source":{"system":"sec-edgar","filing":"0000904454-26-000260","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000260/edgar.xml","form_type":"4"}},{"id":781967,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-05-12T20:54:32.000Z","date":"2026-05-08","kind":"exercise","planned":true,"acquired":true,"shares":25000,"price":5.59,"value":139750.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on September 26, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934."}],"balance_after":214669,"source":{"system":"sec-edgar","filing":"0000904454-26-000260","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000260/edgar.xml","form_type":"4"}},{"id":855470,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-06T21:59:40.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":67200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":67200,"derivative":{"exercise_price":9.04,"expiration_date":"2036-03-04","underlying":"Ordinary Shares","underlying_shares":67200},"source":{"system":"sec-edgar","filing":"0000904454-26-000161","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000161/edgar.xml","form_type":"4"}},{"id":855469,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:59:40.000Z","date":"2026-03-04","kind":"sale","planned":false,"acquired":false,"shares":808,"price":9.06,"value":7320.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote."}],"balance_after":189669,"source":{"system":"sec-edgar","filing":"0000904454-26-000161","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000161/edgar.xml","form_type":"4"}},{"id":855468,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-06T21:59:40.000Z","date":"2026-03-04","kind":"grant","planned":false,"acquired":true,"shares":41700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":190477,"source":{"system":"sec-edgar","filing":"0000904454-26-000161","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000161/edgar.xml","form_type":"4"}},{"id":860717,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-04T21:25:06.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":1660,"price":9.95,"value":16517.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.67 to $10.25. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":148777,"source":{"system":"sec-edgar","filing":"0000904454-26-000148","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445426000148/edgar.xml","form_type":"4"}},{"id":1097576,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-07-01T20:49:12.000Z","date":"2025-06-27","kind":"sale","planned":false,"acquired":false,"shares":1466,"price":13.92,"value":20406.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $13.90 to $14.05. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":150437,"source":{"system":"sec-edgar","filing":"0000904454-25-000350","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445425000350/edgar.xml","form_type":"4"}},{"id":1221673,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-05T22:28:57.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":66000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":66000,"derivative":{"exercise_price":10.9,"expiration_date":"2035-03-03","underlying":"Ordinary Shares","underlying_shares":66000},"source":{"system":"sec-edgar","filing":"0000904454-25-000180","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445425000180/edgar.xml","form_type":"4"}},{"id":1221672,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-05T22:28:57.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":1350,"price":10.29,"value":13891.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.25 to $10.35. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":151903,"source":{"system":"sec-edgar","filing":"0000904454-25-000180","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445425000180/edgar.xml","form_type":"4"}},{"id":1221671,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-05T22:28:57.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":153253,"source":{"system":"sec-edgar","filing":"0000904454-25-000180","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445425000180/edgar.xml","form_type":"4"}},{"id":1467005,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2024-06-28T20:21:42.000Z","date":"2024-06-26","kind":"sale","planned":false,"acquired":false,"shares":1447,"price":4.36,"value":6308.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were sold upon the vesting of restricted share units solely to cover estimated withholding taxes, pursuant to automatic sale instructions included in the relevant Restricted Share Unit Agreement. The sale was not a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.35 to $4.36. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":115253,"source":{"system":"sec-edgar","filing":"0000904454-24-000409","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445424000409/edgar.xml","form_type":"4"}},{"id":1594197,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-05T22:10:37.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":85500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option vests 25% on the first anniversary of the date of grant, and 6.25% quarterly thereafter until fully vested, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":85500,"derivative":{"exercise_price":5.59,"expiration_date":"2034-03-01","underlying":"Ordinary Shares","underlying_shares":85500},"source":{"system":"sec-edgar","filing":"0000904454-24-000199","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445424000199/edgar.xml","form_type":"4"}},{"id":1594196,"issuer":{"id":4162,"kind":"organization","name":"uniQure N.V."},"owners":[{"id":32642,"kind":"person","name":"Abi-Saab Walid","position":1,"cik":"0001985973","reported_name":"Abi-Saab Walid","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Ordinary Shares","published_at":"2024-03-05T22:10:37.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":49500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted share units granted to the Reporting Person under the Issuer's 2014 Share Incentive Plan, as amended and restated. Each restricted share unit represents the contingent right to receive one Ordinary Share. The restricted share units vest in equal annual installments of 1/3 each, beginning on the first anniversary of the date of grant, subject to the Reporting Person's continued relationship with the Issuer through such dates."}],"balance_after":116700,"source":{"system":"sec-edgar","filing":"0000904454-24-000199","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590560/000090445424000199/edgar.xml","form_type":"4"}}]}